SCIASCIA THOMAS
SEC CIK 1229946 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| TRVI | Trevi Therapeutics, Inc. | CSO | 221.4K | — | $289.6K | 8 | 2024-05-29 | 2025-03-25 |
Most active insiders at TRVI, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Heffernan Michael Thomas | Dir | — | $595.8K |
| 2 | Galletta Christopher | See Remarks | — | — |
SCIASCIA THOMAS made no open-market trades at TRVI in the last 12 months.
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-26 | 2025-03-25 | TRVI | Trevi Therapeutics, Inc. | SCIASCIA THOMAS | CSO | S - Sale+OE | $6.60 | -2,631 | 221.4K | -1% | -$17.4K |
| D | 2025-03-26 | 2025-03-25 | TRVI | Trevi Therapeutics, Inc. | SCIASCIA THOMAS | CSO | M - OptEx | $1.43 | +2,631 | 224.0K | +1% | +$3,762 |
| D | 2024-08-21 | 2024-08-19 | TRVI | Trevi Therapeutics, Inc. | SCIASCIA THOMAS | CSO | M - OptEx | $1.43 | +16.5K | 236.8K | +7% | +$23.6K |
| D | 2024-08-21 | 2024-08-19 | TRVI | Trevi Therapeutics, Inc. | SCIASCIA THOMAS | CSO | S - Sale+OE | $2.96 | -16.5K | 220.3K | -7% | -$48.8K |
| DM | 2024-08-16 | 2024-08-14+ | TRVI | Trevi Therapeutics, Inc. | SCIASCIA THOMAS | CSO | M - OptEx | $1.43 | +31.5K | 220.4K | +17% | +$45.1K |
| DM | 2024-08-16 | 2024-08-14+ | TRVI | Trevi Therapeutics, Inc. | SCIASCIA THOMAS | CSO | S - Sale+OE | $2.77 | -31.5K | 220.3K | -13% | -$87.3K |
| D | 2024-05-31 | 2024-05-29 | TRVI | Trevi Therapeutics, Inc. | SCIASCIA THOMAS | CSO | S - Sale+OE | $2.55 | -53.4K | 214.4K | -20% | -$136.1K |
| D | 2024-05-31 | 2024-05-29 | TRVI | Trevi Therapeutics, Inc. | SCIASCIA THOMAS | CSO | M - OptEx | $2.19 | +59.4K | 267.8K | +28% | +$130.0K |
Purchase Sale Sale after option exercise All abbreviations